Keywords
Genetically modified mouseNeurosciencePathogenesisTransgenePathologyBiologyExtracellularDiseaseAlzheimer's diseaseMedicineCell biologyGeneGenetics
Affiliated Institutions
Related Publications
Amyloid-β/Fyn–Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Alzheimer's disease (AD), the most common neurodegenerative disorder, is a growing public health problem and still lacks effective treatments. Recent evidence suggests that micr...
Tau is essential to β-amyloid-induced neurotoxicity
Senile plaques and neurofibrillary tangles, the two hallmark lesions of Alzheimer's disease, are the results of the pathological deposition of proteins normally present througho...
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Many potential treatments for Alzheimer's disease target amyloid-β peptides (Aβ), which are widely presumed to cause the disease. The microtubule-associated protein tau is also ...
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
<b><i>Background:</i></b> We aimed to investigate the influence of oligomeric forms of β-amyloid (Aβ) and the influence of the duration of exposure on th...
Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP
JNPL3 transgenic mice expressing a mutant tau protein, which develop neurofibrillary tangles and progressive motor disturbance, were crossed with Tg2576 transgenic mice expressi...
Publication Info
- Year
- 2005
- Type
- article
- Volume
- 11
- Issue
- 4
- Pages
- 170-176
- Citations
- 453
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
453
OpenAlex
Cite This
Frank M. LaFerla,
Salvatore Oddo
(2005).
Alzheimer's disease: Aβ, tau and synaptic dysfunction.
Trends in Molecular Medicine
, 11
(4)
, 170-176.
https://doi.org/10.1016/j.molmed.2005.02.009
Identifiers
- DOI
- 10.1016/j.molmed.2005.02.009